General Statement of Disclosure:
OTHER FINANCIAL BENEFIT: King Pharmaceuticals, Inc. (now part of Pfizer - October 2010)(MODEST), Alnylam(MODEST)
OTHER FINANCIAL BENEFIT: King Pharmaceuticals, Inc. (now part of Pfizer - October 2010)(MODEST), Alnylam(MODEST)
© 2024 American College of Cardiology Foundation. All rights reserved.